BRCA1

Results: 365



#Item
11FEDERAL COURT OF AUSTRALIA D’Arcy v Myriad Genetics IncFCAFC 115 Citation: D’Arcy v Myriad Genetics IncFCAFC 115

FEDERAL COURT OF AUSTRALIA D’Arcy v Myriad Genetics IncFCAFC 115 Citation: D’Arcy v Myriad Genetics IncFCAFC 115

Add to Reading List

Source URL: sullivanlaw.net

Language: English - Date: 2014-09-05 15:17:17
12Evolutionary dynamics of BRCA1 alterations in breast tumorigenesis

Evolutionary dynamics of BRCA1 alterations in breast tumorigenesis

Add to Reading List

Source URL: michorlab.dfci.harvard.edu

Language: English - Date: 2011-01-27 18:51:16
131 Dr Sunil R Lakhani State Director, Anatomical Pathology, Pathology Queensland. Professor and Head, Molecular and Cellular Pathology, School of Medicine, University of Queensland.

1 Dr Sunil R Lakhani State Director, Anatomical Pathology, Pathology Queensland. Professor and Head, Molecular and Cellular Pathology, School of Medicine, University of Queensland.

Add to Reading List

Source URL: whobluebooks.iarc.fr

Language: English - Date: 2015-10-29 10:08:22
141 Dr Stuart J. Schnitt Director, Division of Anatomic Pathology, Beth Israel Deaconess Medical Center Professor of Pathology, Harvard Medical School

1 Dr Stuart J. Schnitt Director, Division of Anatomic Pathology, Beth Israel Deaconess Medical Center Professor of Pathology, Harvard Medical School

Add to Reading List

Source URL: whobluebooks.iarc.fr

Language: English - Date: 2015-10-29 10:08:23
15Features EMQN Feature New pilot EQA for BRCA testing in ovarian cancer The introduction of targeted treatment for ovarian cancer in patients with germline and somatic BRCA1 and BRCA2 mutations

Features EMQN Feature New pilot EQA for BRCA testing in ovarian cancer The introduction of targeted treatment for ovarian cancer in patients with germline and somatic BRCA1 and BRCA2 mutations

Add to Reading List

Source URL: www.emqn.org

- Date: 2015-08-20 11:21:01
    16Final results of the phase I first-in-man trial of niraparib (MK4827), a poly(ADP)ribose polymerase (PARP) inhibitor incorporating proof of concept biomarker studies and expansion cohorts involving BRCA1/2 mutation carri

    Final results of the phase I first-in-man trial of niraparib (MK4827), a poly(ADP)ribose polymerase (PARP) inhibitor incorporating proof of concept biomarker studies and expansion cohorts involving BRCA1/2 mutation carri

    Add to Reading List

    Source URL: www.tesarobio.com

    Language: English - Date: 2013-06-03 17:45:31
      17若手研究者インターナショナル・トレーニング・プログラム(ITP) バイオインフォマティクスとシステムズバイオロジーの国際連携教育研究プログラム 応募書類 Name:

      若手研究者インターナショナル・トレーニング・プログラム(ITP) バイオインフォマティクスとシステムズバイオロジーの国際連携教育研究プログラム 応募書類 Name:

      Add to Reading List

      Source URL: www.bic.kyoto-u.ac.jp

      Language: English - Date: 2014-08-18 20:02:20
      18BRCA1 Is Required for Postreplication Repair after UV-Induced DNA Damage

      BRCA1 Is Required for Postreplication Repair after UV-Induced DNA Damage

      Add to Reading List

      Source URL: cegs1.dfci.harvard.edu

      Language: English - Date: 2012-02-17 17:08:01
        19Judgment and Decision Making, Vol. 10, No. 4, July 2015, pp. 386–399 Willingness to test for BRCA1/2 in high risk women: Influenced by risk perception and family experience, rather than by objective or subjective nume

        Judgment and Decision Making, Vol. 10, No. 4, July 2015, pp. 386–399 Willingness to test for BRCA1/2 in high risk women: Influenced by risk perception and family experience, rather than by objective or subjective nume

        Add to Reading List

        Source URL: www.decisionsciencenews.com

        Language: English - Date: 2015-08-02 14:49:31
          20 I bodywise much as $14 million among approximately 70 researchers.

          I bodywise much as $14 million among approximately 70 researchers. "Some of the most recent research is the most exciting," says Lauder,

          Add to Reading List

          Source URL: amyblumenfeld.com

          Language: English - Date: 2015-04-09 14:57:51